Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Combining QCM and SERS on a Nanophotonic Chip: A Dual-Functional Sensor for Biomolecular Interaction Analysis and Protein Fingerprinting.

Nanomaterials (Basel, Switzerland)·2025

Same author

Development of a New AMBER Force Field for Cysteine and Histidine Cadmium-Binding Proteins and Its Validation Through QM/MM MD Simulations.

Journal of computational chemistry·2025

Same author

PDBrestore: A Free Web Interface for Processing and Fixing Protein Chains From Raw PDB Files.

Journal of computational chemistry·2025

Same author

Methodological and force field effects in the molecular dynamics-based prediction of binding free energies of host-guest systems.

Physical chemistry chemical physics : PCCP·2024

Same author

Identification of Potential Inhibitors of the SARS-CoV-2 NSP13 Helicase via Structure-Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations.

ChemMedChem·2024

Same author

Addressing Suboptimal Poses in Nonequilibrium Alchemical Calculations.

The journal of physical chemistry. B·2024

Same journal

The Anionic States of Ubiquinone Characterized by Second-Order Approximate Coupled-Cluster Theory.

Journal of computational chemistry·2026

Same journal

Hydrogen Bond Energy Estimation in Large Molecular Clusters via the Method of Synergistic Cyclic Cooperativity: A Software Update H-BEE 2.0.

Journal of computational chemistry·2026

Same journal

The Intricate Mechanism of Nitric Oxide Synthase.

Journal of computational chemistry·2026

Same journal

A Molecular "Thermometer" for Measuring Effective Non-Local Exchange.

Journal of computational chemistry·2026

Same journal

Insights to Orientation Dependence of Molecular Conduction Modeled by High-Level Quantum Embedding.

Journal of computational chemistry·2026

Same journal

AutoSTOP-RT-TDDFT: Adaptive and Selected Real-Time Time-Dependent Density Functional Theory for Simulation of X-Ray Absorptions.

Journal of computational chemistry·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

PrimaDORAC: An improved Web Interface for Rapid GAFF2 Parameter Assignment with ABCG2 Charge Models for Drug Design

Piero Procacci¹

¹Department of Chemistry, University of Florence, Florence, Italy.

Journal of Computational Chemistry

|June 19, 2026

Summary

This summary is machine-generated.

The PrimaDORAC web interface now offers easy access to ABCG2 charges for GAFF2 molecular dynamics simulations, improving accuracy without software installation. This empowers drug design researchers with advanced computational tools.

More Related Videos

An Open-Source Framework for Mass Calculation of Antibody-Based Therapeutic Molecules

An Open-Source Framework for Mass Calculation of Antibody-Based Therapeutic Molecules

Published on: June 16, 2023

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Experiment Videos

Last Updated: Jun 20, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

An Open-Source Framework for Mass Calculation of Antibody-Based Therapeutic Molecules

An Open-Source Framework for Mass Calculation of Antibody-Based Therapeutic Molecules

Published on: June 16, 2023

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Area of Science:

Computational chemistry
Drug design
Molecular modeling

Background:

Accurate molecular parameterization is crucial for molecular dynamics (MD) simulations in structure-based drug design.
The AM1-BCC charge model has been the standard for GAFF2 parameterization for 20 years.
The newer ABCG2 model provides enhanced accuracy for hydration free energies and physicochemical properties.

Purpose of the Study:

To upgrade the PrimaDORAC web interface for simplified access to ABCG2 parameters.
To remove technical barriers associated with installing the AmberTools suite for ABCG2 parameterization.
To make state-of-the-art molecular parameterization accessible to the broader drug design community.

Main Methods:

Minimalistic integration of essential AmberTools components into the PrimaDORAC web application.
Users submit a SMILES string or structure file.
The interface processes the input and returns GROMACS-compatible topology files and a PDB structure.

Main Results:

The upgraded PrimaDORAC interface provides rapid (seconds) GAFF2 parameterization with ABCG2 charges.
No software installation is required, significantly lowering the barrier to entry.
Users receive a complete archive with GROMACS-compatible files and a PDB structure.

Conclusions:

The PrimaDORAC interface democratizes access to accurate ABCG2 parameters for MD simulations.
Medicinal chemists, pharmacologists, and computational researchers can now perform more precise simulations with ease.
This advancement facilitates more efficient and accurate structure-based drug design.